Performance in population models for count data, part I: maximum likelihood approximations

There has been little evaluation of maximum likelihood approximation methods for non-linear mixed effects modelling of count data. The aim of this study was to explore the estimation accuracy of population parameters from six count models, using two different methods and programs. Simulations of 100 data sets were performed in NONMEM for each probability distribution with parameter values derived from a real case study on 551 epileptic patients. Models investigated were: Poisson (PS), Poisson with Markov elements (PMAK), Poisson with a mixture distribution for individual observations (PMIX), Zero Inflated Poisson (ZIP), Generalized Poisson (GP) and Negative Binomial (NB). Estimations of simulated datasets were completed with Laplacian approximation (LAPLACE) in NONMEM and LAPLACE/Gaussian Quadrature (GQ) in SAS. With LAPLACE, the average absolute value of the bias (AVB) in all models was 1.02% for fixed effects, and ranged 0.32–8.24% for the estimation of the random effect of the mean count (λ). The random effect of the overdispersion parameter present in ZIP, GP and NB was underestimated (−25.87, −15.73 and −21.93% of relative bias, respectively). Analysis with GQ 9 points resulted in an improvement in these parameters (3.80% average AVB). Methods implemented in SAS had a lower fraction of successful minimizations, and GQ 9 points was considerably slower than 1 point. Simulations showed that parameter estimates, even when biased, resulted in data that were only marginally different from data simulated from the true model. Thus all methods investigated appear to provide useful results for the investigated count data models.

[1]  N. Breslow,et al.  Bias Correction in Generalized Linear Mixed Models with Multiple Components of Dispersion , 1996 .

[2]  Mats O. Karlsson,et al.  Modelling overdispersion and Markovian features in count data , 2009, Journal of Pharmacokinetics and Pharmacodynamics.

[3]  John P Elder,et al.  Epidemiologic Perspectives & Innovations Open Access a Demonstration of Modeling Count Data with an Application to Physical Activity , 2022 .

[4]  L B Sheiner,et al.  Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic data. , 1984, Drug metabolism reviews.

[5]  Lewis B. Sheiner,et al.  Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data , 1981, Journal of Pharmacokinetics and Biopharmaceutics.

[6]  Siv Jönsson,et al.  Estimating Bias in Population Parameters for Some Models for Repeated Measures Ordinal Data Using NONMEM and NLMIXED , 2004, Journal of Pharmacokinetics and Pharmacodynamics.

[7]  Lewis B. Sheiner,et al.  Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic data , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[8]  Noreen Goldman,et al.  An assessment of estimation procedures for multilevel models with binary responses , 1995 .

[9]  Evaluation of Mixture Modeling with Count Data Using NONMEM , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[10]  R. Savic,et al.  Pharmacokinetics of Desmopressin Administrated as an Oral Lyophilisate Dosage Form in Children With Primary Nocturnal Enuresis and Healthy Adults , 2006, Journal of clinical pharmacology.

[11]  R. Winkelmann,et al.  Count data models for demographic data. , 1994, Mathematical population studies.

[12]  James W Hardin,et al.  Testing Approaches for Overdispersion in Poisson Regression versus the Generalized Poisson Model , 2007, Biometrical journal. Biometrische Zeitschrift.

[13]  M O Karlsson,et al.  Diagnosing Model Diagnostics , 2007, Clinical pharmacology and therapeutics.

[14]  L B Sheiner,et al.  Quantitative characterization of therapeutic index: Application of mixed‐effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships , 1999, Clinical pharmacology and therapeutics.

[15]  N H Holford,et al.  Simulation of clinical trials. , 2000, Annual review of pharmacology and toxicology.

[16]  Yaning Wang Derivation of various NONMEM estimation methods , 2007, Journal of Pharmacokinetics and Pharmacodynamics.

[17]  Sylvie Chabaud,et al.  Clinical Trial Simulation Using Therapeutic Effect Modeling: Application to Ivabradine Efficacy in Patients with Angina Pectoris , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[18]  Lewis B. Sheiner,et al.  Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data , 1980, Journal of Pharmacokinetics and Biopharmaceutics.

[19]  M. Puterman,et al.  Mixed Poisson regression models with covariate dependent rates. , 1996, Biometrics.